Table 3

Association between tHcy and intracranial aneurysm

Before matchedAfter matched
Crude ORModel 1*Model 2†Crude ORModel 1*Model 2†
Adjusted ORAdjusted ORAdjusted ORAdjusted OR
95% CIP95% CIP95% CIP95% CIP95% CIP95% CIP
tHcy‡ (SD), μmol/L1.23 (1.18 to 1.28)<0.0011.50 (1.43 to 1.57)<0.0011.50 (1.43 to 1.57)<0.0011.82 (1.70 to 1.95)<0.0011.99 (1.85 to 2.13)<0.0011.98 (1.85 to 2.14)<0.001
tHcy§1.13 (1.11 to 1.16)<0.0011.30 (1.24 to 1.33)<0.0011.29 (1.25 to 1.33)<0.0011.44 (1.38 to 1.50)<0.0011.51 (1.45 to 1.59)<0.0011.52 (1.45 to 1.59)<0.001
Group tHcy, number (%) <0.001¶ <0.001¶ <0.001¶
 LowReference.Reference.Reference.Reference.Reference.Reference.
 Moderate1.38 (1.27 to 1.49)<0.0011.72 (1.47 to 2.00)<0.0011.71 (1.61 to 1.82)<0.0012.13 (1.93 to 2.36)<0.0012.70 (2.19 to 3.37)<0.0011.80 (1.67 to 1.94)<0.001
 High1.97 (1.60 to 2.42)<0.0010.94 (0.85 to 1.05)0.2812.06 (1.76 to 2.40)<0.0013.66 (2.71 to 4.95)<0.0010.90 (0.78 to 1.04)0.2002.69 (2.17 to 3.34)<0.001
 Moderate+high1.43 (1.32 to 1.54)<0.0011.59 (1.50 to 1.69)<0.0012.20 (2.02 to 2.39)<0.0012.24 (2.03 to 2.47)<0.0011.88 (1.75 to 2.02)<0.0011.87 (1.74 to 2.00)<0.001
  • P-value for OR (odd ratios) was based on Wald tests.

  • *Adjusted for age, sex, hypertension and smoking.

  • †Adjusted for variables from Model 1 plus dyslipidaemia and diabetes.

  • ‡: OR was estimated by one standard difference increase of tHcy (8.2 µmol/L).

  • §: OR was estimated by a increase of 5 µmol/L of tHcy.

  • ¶: P value for trend.

  • tHcy, total homocysteine.